Pale Fire Capital SE »

Cullinan Oncology shares owned by Pale Fire Capital SE

Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by Pale Fire Capital SE from 13F filings

Historical chart of Pale Fire Capital SE investment in Cullinan Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cullinan Oncology held by Pale Fire Capital SE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cullinan Oncology by Pale Fire Capital SE

Quarter filed Position value Share count Share price at filing
2025-09-30 $87k 15k 5.93

More positions owned by Pale Fire Capital SE

B2gold Corp (BTG)
Groupon Com New (GRPN)
Dole Ord Shs (DOLE)
Iamgold Corp (IAG)
New Gold Inc Cda (NGD)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Centerra Gold (CGAU)
Angi Cl A New (ANGI)
I-80 Gold Corp (IAUX)
Mineralys Therapeutics (MLYS)
J Global (ZD)
Galiano Gold (GAU)
Tsakos Energy Navigation SHS (TEN)
Atai Life Sciences Nv SHS (ATAI)
Liquidia Corporation Com New (LQDA)

View all positions for Pale Fire Capital SE

Top funds holding Cullinan Oncology

MPM Oncology Impact Management
Lynx1 Capital Management
BVF
BlackRock
Vanguard Group
Deerfield Management Company
Blue Owl Capital Holdings
Kynam Capital Management
Citadel Advisors
OrbiMed Advisors
Rtw Investments
State Street Corporation
Franklin Resources
VR Adviser
Geode Capital Management

View all funds holding Cullinan Oncology